Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program

Agency: Other Defense Agencies
State: Texas
Type of Government: Federal
Category:
  • 65 - Medical, Dental, and Veterinary Equipment and Supplies
Posted: Oct 8, 2019
Due: Oct 30, 2019
Solicitation No: HT9402-19-Q-0006(3)
Publication URL: To access bid details, please log in.
Opportunity History
  • Original Synopsis
    Oct 08, 2019
    12:33 pm
Solicitation Number :
HT9402-19-Q-0006(3)
Notice Type :
Combined Synopsis/Solicitation
Synopsis :
Added: Oct 08, 2019 12:33 pm
Background:
The Department of Defense (DoD) is required by law (10 U.S.C. ยง 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoD Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoD Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ.

P&T COMMITTEE MEETING: November 2019: The following drug classes/subclass and newly approved agents will be reviewed:
Antidepressants and Non-Opioid Pain Syndrome Agents, SUB CLASS: Serotonin-Norepinephrine Reuptake Inhibitors - Drizalma
Pulmonary-2 Agents, SUB CLASS: Chronic Obstructive Pulmonary Disease - Duaklir Pressair
Binders Chelators Antidotes Overdose, SUB CLASS: NA - Gvoke
Anticonvulsants-Antimania Agents, SUB CLASS: NA - Nayzilam
Parkinsons Agents, SUB CLASS: NA - Nourianz
Diabetes Non-Insulin, SUB CLASS: Glucagon-Like Peptide-1 (GLP) Receptor Agonists Oral - Rybelsus
Diabetes Non-Insulin, SUB CLASS: Glucagon-Like Peptide-1 (GLP) Receptor Agonists - Rybelsus
Migraine Agents, SUB CLASS: Triptans - Tosymra
Sleep Disorders, SUB CLASS: Wakefulness Promoting Agents - Wakix


RFQ: The RFQ, including UF BPA and UF ADP appendices are attached herein.
There is no pre-proposal teleconference. Rather, questions shall be submitted via e-mail to the Request for Quote (RFQ) Point of Contact stated in Part 2.3, no later than the date stated in Part 2.4. Also, responses to Part 3.4 is required.


POCs: Part 2.3 of the RFQ.
For additional information, search DoD Pharmacy and Therapeutics (P&T) Committee at http://www.health.mil/POD

Please consult the list of document viewers if you cannot open a file.
Newly Approved Drug Appendices
Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
Newly Approved Drug Appendices
Posted Date:
October 8, 2019
NAD_Appendix3_-_Drizalma-_Antidepressants_and_Non-Op... (32.98 Kb)
Download/View NAD_Appendix3_-_Drizalma-_Antidepressants_and_Non-Opioid_Pain_Syndrome_Agents_-_Serotonin-Norepinephrine_Reuptake_Inhibitors.docx
Description: NAD Appendix3 - Drizalma- Antidepressants and Non-Opioid Pain Syndrome Agents - Serotonin-Norepinephrine Reuptake Inhibitors
NAD_Appendix3_-_Duaklir_Pressair_-_Pulmonary-2_Agent... (31.21 Kb)
Download/View NAD_Appendix3_-_Duaklir_Pressair_-_Pulmonary-2_Agents_-_Chronic_Obstructive_Pulmonary_Disease.docx
Description: NAD Appendix3 - Duaklir Pressair - Pulmonary-2 Agents - Chronic Obstructive Pulmonary Disease
NAD_Appendix3_-_Gvoke_-_Binders_Chelators_Antidotes_... (31.24 Kb)
Download/View NAD_Appendix3_-_Gvoke_-_Binders_Chelators_Antidotes_Overdose_-_NA.docx
Description: NAD Appendix3 - Gvoke - Binders Chelators Antidotes Overdose - NA
NAD_Appendix3_-_Nayzilam-_Anticonvulsants-Antimania_... (31.34 Kb)
Download/View NAD_Appendix3_-_Nayzilam-_Anticonvulsants-Antimania_Agents_-_NA.docx
Description: NAD Appendix3 - Nayzilam- Anticonvulsants-Antimania Agents - NA
NAD_Appendix3_-_Nourianz_-_Parkinsons_Agents_-_NA.do... (31.15 Kb)
Download/View NAD_Appendix3_-_Nourianz_-_Parkinsons_Agents_-_NA.docx
Description: NAD Appendix3 - Nourianz - Parkinsons Agents - NA
NAD_Appendix3_-_Rybelsus_-_Diabetes_Non-Insulin_-_Gl... (31.60 Kb)
Download/View NAD_Appendix3_-_Rybelsus_-_Diabetes_Non-Insulin_-_Glucagon-Like_Peptide-1_(GLP)_Receptor_Agonists_Oral.docx
Description: NAD Appendix3 - Rybelsus - Diabetes Non-Insulin - Glucagon-Like Peptide-1 (GLP) Receptor Agonists Oral
NAD_Appendix3_-_Rybelsus_-_Diabetes_Non-Insulin_-_Gl... (31.25 Kb)
Download/View NAD_Appendix3_-_Rybelsus_-_Diabetes_Non-Insulin_-_Glucagon-Like_Peptide-1_(GLP1)_Receptor_Agonists.docx
Description: NAD Appendix3 - Rybelsus - Diabetes Non-Insulin - Glucagon-Like Peptide-1 (GLP1) Receptor Agonists
NAD_Appendix3_-_Tosymra_-_Migraine_Agents_-_Triptans... (32.15 Kb)
Download/View NAD_Appendix3_-_Tosymra_-_Migraine_Agents_-_Triptans.docx
Description: NAD Appendix3 - Tosymra - Migraine Agents - Triptans
NAD_Appendix3_-_Wakix_-_Sleep_Disorders_-_Wakefulnes... (31.26 Kb)
Download/View NAD_Appendix3_-_Wakix_-_Sleep_Disorders_-_Wakefulness_Promoting_Agents.docx
Description: NAD Appendix3 - Wakix - Sleep Disorders - Wakefulness Promoting Agents
RFQ Newly Approved Drugs
Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
RFQ Newly Approved Drugs
Posted Date:
October 8, 2019
Description: Solicitation for Newly Approved Drugs
Contracting Office Address :
16401 E. Centretech Pkwy
Aurora, Colorado 80011
United States
Place of Performance :
7800 IH-10 West, Ste 400
San Antonio, Texas 78230
United States
Primary Point of Contact. :
Alexia Ray,
Contract Analyst, CTR
Phone: 210-536-6020
Secondary Point of Contact :
Yvette H. Dluhos,
Contract Specialist
Phone: 210-536-6048
All Files
Newly Approved Drug Appendices
Oct 08, 2019
NAD_Appendix3_-_Driz...
Download/View NAD_Appendix3_-_Drizalma-_Antidepressants_and_Non-Opioid_Pain_Syndrome_Agents_-_Serotonin-Norepinephrine_Reuptake_Inhibitors.docx
NAD_Appendix3_-_Duak...
Download/View NAD_Appendix3_-_Duaklir_Pressair_-_Pulmonary-2_Agents_-_Chronic_Obstructive_Pulmonary_Disease.docx
NAD_Appendix3_-_Gvok...
Download/View NAD_Appendix3_-_Gvoke_-_Binders_Chelators_Antidotes_Overdose_-_NA.docx
NAD_Appendix3_-_Nayz...
Download/View NAD_Appendix3_-_Nayzilam-_Anticonvulsants-Antimania_Agents_-_NA.docx
NAD_Appendix3_-_Nour...
Download/View NAD_Appendix3_-_Nourianz_-_Parkinsons_Agents_-_NA.docx
NAD_Appendix3_-_Rybe...
Download/View NAD_Appendix3_-_Rybelsus_-_Diabetes_Non-Insulin_-_Glucagon-Like_Peptide-1_(GLP)_Receptor_Agonists_Oral.docx
NAD_Appendix3_-_Rybe...
Download/View NAD_Appendix3_-_Rybelsus_-_Diabetes_Non-Insulin_-_Glucagon-Like_Peptide-1_(GLP1)_Receptor_Agonists.docx
NAD_Appendix3_-_Tosy...
Download/View NAD_Appendix3_-_Tosymra_-_Migraine_Agents_-_Triptans.docx
NAD_Appendix3_-_Waki...
Download/View NAD_Appendix3_-_Wakix_-_Sleep_Disorders_-_Wakefulness_Promoting_Agents.docx
RFQ Newly Approved Drugs
Oct 08, 2019
RFQ__HT9402-19-Q-000...
Download/View RFQ__HT9402-19-Q-0006(3).pdf
General Information
Notice Type:
Combined Synopsis/Solicitation
Posted Date:
October 8, 2019
Response Date:
Oct 30, 2019 12:00 pm Central
Archiving Policy:
Manual Archive
Archive Date:
-
Original Set Aside:
N/A
Set Aside:
N/A
Classification Code:
65 -- Medical, dental & veterinary equipment & supplies
NAICS Code:
325 -- Chemical Manufacturing/325412 -- Pharmaceutical Preparation Manufacturing
Daily notification on new contract opportunities

With GovernmentContracts, you can:

  • Find more opportunities and win more business
  • Receive daily alerts for all new bid opportunities
  • Get contract opportunities matched to your business
ONE WEEK FREE TRIAL

See also

rfp title posted deadline Awards, Incentives and Spirit Apparel RFP# PURCH 1819-2 (eBid)

Aldine School District

Bid Due: 6/30/2020

rfp title posted deadline Photography Services RFP# PURCH 1819-4 07/15/19 06/30/20

Aldine School District

Bid Due: 6/30/2020

Opportunity History Original Synopsis Jul 16, 2019 4:37 pm Solicitation Number : NNH16ZCQ001K-CDFF

National Aeronautics and Space Administration

Bid Due: 9/30/2020

Bid Information Type Request for Proposal - Informal Status Issued Number 031-18-004 (HVAC

Round Rock Independent School District (Round Rock ISD)

Bid Due: 7/01/2021

* Disclaimer: Information regarding bids, requests for proposals (RFPs), or requests for qualifications (RFQs) is provided on this website only as a convenience and does not constitute official public notice. Persons wishing to respond to or inquire about bids, RFPs, or RFQs should contact the appropriate government department.